XJPX
6029
Market cap12mUSD
Oct 09, Last price
192.00JPY
1D
1.59%
1Q
-2.04%
Jan 2017
-73.52%
IPO
-34.55%
Name
Artra Group Corp
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Artra Group Corporation delivers diverse support services to acupuncture and osteopathic clinics across Japan. Its offerings encompass billing solutions and HONEY-STYLE, a specialized platform facilitating word-of-mouth marketing and reservation management for acupuncture and moxibustion practices. The company also operates the Atlas Store, an e-commerce site providing essential consumables for these facilities. Additionally, it runs a portal site, accessible via its website and e-mail magazine, which distributes information to judo reduction instructors, acupuncturists/moxibustion practitioners, and anma massage shiatsu therapists. Nursing care services are also part of its portfolio. Formerly known as artra corporation, the company adopted its present name, Artra Group Corporation, in 2021. Founded in 2005, its headquarters are situated in Osaka, Japan.
Key people
Hiroyuki Kyuse
Chairman of the Board, President, Chief Executive Officer, Manager of President's Office, Representative Director · since 2025
Masaki Tanaka
Chief Financial Officer, Director · since 2018
Katsunori Tanaka
Director of General Affairs and Human Resources, Director · since 2024
Munehiro Aratani
Director · since 2025
Toru Katada
Director · since 2025
Jun Iwata
Independent Director · since 2017
Yoshifumi Okumura
Independent Director · since 2017
Independent Director · since 2015
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||